STOCK TITAN
  1. Home
  2. Sec-filings
  3. GLTO
  4. [EFFECT] Galecto, Inc. SEC Filing

[EFFECT] Galecto, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 23, 2025 4:01 P.M.
Form: S-3
CIK: 0001800315
Company Name: Galecto, Inc.
File Number: 333-292175

Source: View Original Filing on SEC EDGAR

Galecto Inc.

NASDAQ:GLTO

View GLTO Stock Overview →

GLTO Rankings

#2295 Ranked by Market Cap
N/A Ranked by Dividends

GLTO Latest News

Mar 9, 2026
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
Mar 4, 2026
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 2, 2026
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
Feb 12, 2026
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million
Feb 10, 2026
Galecto Announces Pricing of $275 Million Underwritten Public Offering

GLTO Latest SEC Filings

Mar 25, 2026
[Form 4] Galecto, Inc. Insider Trading Activity
Mar 25, 2026
[Form 4] Galecto, Inc. Insider Trading Activity
Mar 25, 2026
[Form 4] Galecto, Inc. Insider Trading Activity
Mar 25, 2026
[Form 4] Galecto, Inc. Insider Trading Activity
Mar 25, 2026
[Form 4] Galecto, Inc. Insider Trading Activity

GLTO Stock Data

1.73B
59.36M
Biotechnology
Pharmaceutical Preparations
Link
Denmark
BOSTON